Radiology in France has made major advances in recent years through innovations in research and clinical practice. French institutions have developed innovative imaging techniques and artificial intelligence applications in the field of diagnostic imaging and interventional radiology. These include, but are not limited to, a more precise diagnosis of cancer and other diseases, research in dual-energy and photon-counting computed tomography, new applications of artificial intelligence, and advanced treatments in the field of interventional radiology. This article aims to explore the major research initiatives and technological advances that are shaping the landscape of radiology in France. By highlighting key contributions in diagnostic imaging, artificial intelligence, and interventional radiology, we provide a comprehensive overview of how these innovations are improving patient outcomes, enhancing diagnostic accuracy, and expanding the possibilities for minimally invasive therapies. As the field continues to evolve, France’s position at the forefront of radiological research ensures that these innovations will play a central role in addressing current healthcare challenges and improving patient care on a global scale.
PellatABaratMCoriatRSoyerPDohanA. Artificial intelligence: a review of current applications in hepatocellular carcinoma imaging. Diagn Interv Imaging. 2023;104(1):24-36.
2.
BaratMPellatAHoeffelC, et al. CT and MRI of abdominal cancers: current trends and perspectives in the era of radiomics and artificial intelligence. Jpn J Radiol. 2024;42(3):246-260.
3.
BaratMPellatADohanAHoeffelCCoriatRSoyerP. CT and MRI of gastrointestinal stromal tumors: new trends and perspectives. Can Assoc Radiol J. 2024;75(1):107-117.
DouekPCBoccaliniSOeiEHG, et al. Clinical applications of photon-counting CT: a review of pioneer studies and a glimpse into the future. Radiology. 2023;309(1):e222432.
6.
BoccaliniSMayardCLacombeH, et al. Ultra-high-resolution and K-edge imaging of prosthetic heart valves with spectral photon-counting CT: a phantom study. Invest Radiol. 2024;59(8):589-598.
7.
de Margerie-MellonCChassagnonG. Artificial intelligence: a critical review of applications for lung nodule and lung cancer. Diagn Interv Imaging. 2023;104(1):11-17.
8.
SapovalMThiounnNDescazeaudA, et al; PARTEM study group. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023;31:100672.
9.
LoffroyRGuillenKSaletE, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles?J Clin Med. 2021;10(14):3161.
10.
TasuJPHerpeGDamionJ, et al. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study. Eur Radiol. 2024;34(10):6885-6895. doi:10.1007/s00330-024-10613-x
11.
CrombéASpinnatoPItalianoA, et al. Radiomics and artificial intelligence for soft-tissue sarcomas: current status and perspectives. Diagn Interv Imaging. 2023;104(12):567-583.
12.
XueCZhouQXiHZhouJ. Radiomics: a review of current applications and possibilities in the assessment of tumor microenvironment. Diagn Interv Imaging. 2023;104(3):113-122.
13.
Masson-GrehaigneCLafonMPalussièreJ, et al. Single- and multi-site radiomics may improve overall survival prediction for patients with metastatic lung adenocarcinoma. Diagn Interv Imaging. Published online August 26, 2024. doi:10.1016/j.diii.2024.07.005
14.
BlayJYPenelNValentinT, et al. Improved nationwide survival of sarcoma patients with a network of reference centers. Ann Oncol. 2024;35(4):351-363.
15.
CrombéAPérierCKindM, et al. T2-based MRI delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapy. J Magn Reson Imaging. 2019;50(2):497-510.
16.
CrombéAKindMFadliD, et al. Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients. Sci Rep. 2020;10(1):15496.
17.
CrombéALucchesiCBertoloF, et al. Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis. NPJ Precis Oncol. 2024;8(1):129.
AlattarYSoulatGGencerU, et al. Left ventricular diastolic early and late filling quantified from 4D flow magnetic resonance imaging. Diagn Interv Imaging. 2022;103(7-8):345-352.
20.
de Villedon de NaideVNarceauKOzenneV, et al. Advanced myocardial MRI tissue characterization combining contrast agent-free T1-rho mapping with fully automated analysis. J Magn Reson Imaging. Published online July 1, 2024. doi:10.1002/jmri.29502
21.
LongèreBAbassebayNGkizasC, et al. A new compressed sensing cine cardiac MRI sequence with free-breathing real-time acquisition and fully automated motion-correction: a comprehensive evaluation. Diagn Interv Imaging. 2023;104(11):538-546.
22.
CadourFCourASenlisJ, et al. How to use MRI in cardiac disease with diastolic dysfunction?Br J Radiol. 2024;97(1159):1203-1213.
23.
CadourFCautelaJRapacchiS, et al. Cardiac MRI features and prognostic value in immune checkpoint inhibitor-induced myocarditis. Radiology. 2022;303(3):512-521.
24.
LecomteASerrandAMarteauL, et al. Coronary artery assessment on pre transcatheter aortic valve implantation computed tomography may avoid the need for additional coronary angiography. Diagn Interv Imaging. 2023;104(11):547-551.
25.
RevelMPAbdoulHChassagnonGCanniffEDurand-ZaleskiIWislezM. Lung cancer screening in French women using low-dose CT and artificial intelligence for detection: the CASCADE study protocol. BMJ Open. 2022;12(12):e067263.
26.
CazierPChassagnonGDhoteT, et al. Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor. Eur Respir J. Published online February 8, 2024. doi:10.1183/13993003.01794-2023
27.
ChassagnonGZacharakiEIBommartS, et al. Quantification of cystic fibrosis lung disease with radiomics-based CT scores. Radiol Cardiothorac Imaging. 2020;2(6):e200022.
28.
Hadj BouzidAIBuiSBenlalaI, et al. Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with/without modulators treatment. Eur Radiol. Published online August 16, 2024. doi:10.1007/s00330-024-11019-5
29.
SaccentiLMellonCMScholerM, et al. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI. Diagn Interv Imaging. 2023;104(9):410-418.
30.
MilonAFlamentVGuenicheY, et al. How to optimize breast MRI protocol? The value of combined analysis of ultrafast and diffusion-weighted MRI sequences. Diagn Interv Imaging. 2023;104(6):284-291.
31.
RamtohulTDjerroudiLLissavalidE, et al. Multiparametric MRI and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers. Radiology. 2023;308(2):e222646.
32.
RamtohulTLepagneyVBonneauC, et al. Use of pretreatment perfusion MRI-based intratumoral heterogeneity to predict pathologic response of triple-negative breast cancer to neoadjuvant chemoimmunotherapy. Radiology. 2024;312(3):e240575.
33.
RoussetPFlorinMBharwaniN, et al; ENDOVALIRM Group. Deep pelvic infiltrating endometriosis: MRI consensus lexicon and compartment-based approach from the ENDOVALIRM group. Diagn Interv Imaging. 2023;104(3):95-112.
34.
Thomassin-NaggaraILamrabetSCrestaniA, et al. Magnetic resonance imaging classification of deep pelvic endometriosis: description and impact on surgical management. Hum Reprod. 2020;35(7):1589-1600.
35.
Thomassin-NaggaraIMonrocMChauveauB, et al. Multicenter external validation of the deep pelvic endometriosis index magnetic resonance imaging score. JAMA Netw Open. 2023;6(5):e2311686.
Thomassin-NaggaraIZouaCSBazotM, et al; ENDOVALIRM study group. Diagnostic MRI for deep pelvic endometriosis: towards a standardized protocol?Eur Radiol. Published online July 3, 2024. doi:10.1007/s00330-024-10842-0.
38.
NougaretSRazakamanantsoaLSadowskiEA, et al. O-RADS MRI risk stratification system: pearls and pitfalls. Insights Imaging. 2024;15(1):45.
39.
SadowskiEARockallAThomassin-NaggaraI, et al. Adnexal lesion imaging: past, present, and future. Radiology. 2023;307(5):e223281.
40.
NougaretSLakhmanYBahadirSSadowskiEThomassin-NaggaraIReinholdC. Ovarian-Adnexal Reporting and Data System for magnetic resonance imaging (O-RADS MRI): genesis and future directions. Can Assoc Radiol J. 2023;74(2):370-381.
41.
PhillipsCHGuoYStrachowskiLMJhaPReinholdCAndreottiRF. The Ovarian/Adnexal Reporting and Data System for ultrasound: from standardized terminology to optimal risk assessment and management. Can Assoc Radiol J. 2023;74(1):44-57.
42.
BourourouRNougaretSRockallABazotMRazakamanantsoaLThomassin-NaggaraI; EURAD Study Group. Apparent diffusion coefficient analysis of solid tissue helps distinguish borderline from invasive malignant adnexal masses rated O-RADS MRI 4. Diagn Interv Imaging. Published online June 14, 2024. doi:10.1016/j.diii.2024.05.004
43.
Thomassin-NaggaraIDabiYFlorinM, et al. O-RADS MRI score: an essential first-step tool for the characterization of adnexal masses. J Magn Reson Imaging. 2024;59(3):720-736.
44.
AvesaniGBonattiMVenkatesanAMNougaretSSalaE. RadioGraphics update: 2023 FIGO staging system for endometrial cancer. Radiographics. 2024;44(7):e240084.
45.
VukusicSCaseyRRollotF, et al. Observatoire Français de la Sclérose en Plaques (OFSEP): a unique multimodal nationwide MS registry in France. Mult Scler. 2020;26(1):118-122.
46.
WattjesMPCiccarelliOReichDS, et al; Magnetic resonance imaging in multiple sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. 2021MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20(8):653-670.
47.
AdoumAMazzoloLLeclerASadikJCSavatovskyJDuronL. Co-registration with subtraction and color-coding or fusion improves the detection of new and growing lesions on follow-up MRI examination of patients with multiple sclerosis. Diagn Interv Imaging. 2023;104(11):529-537.
48.
LespagnolMMassireAMegdicheI, et al. Improved detection of juxtacortical lesions using highly accelerated double inversion-recovery MRI in patients with multiple sclerosis. Diagn Interv Imaging. 2023;104(9):401-409.
49.
LinckPAKuchcinskiGMunschF, et al. Neurodegeneration of the substantia nigra after ipsilateral infarct: MRI R2* mapping and relationship to clinical outcome. Radiology. 2019;291(2):438-448.
50.
HamonGLegrandLHmeydiaG, et al. Multicenter validation of synthetic FLAIR as a substitute for FLAIR sequence in acute ischemic stroke. Eur Stroke J. Published online August 3, 2024. doi:10.1177/23969873241263418
51.
Bani-SadrAEscandeRMechtouffL, et al. Vascular hyperintensities on baseline FLAIR images are associated with functional outcome in stroke patients with successful recanalization after mechanical thrombectomy. Diagn Interv Imaging. 2023;104(7-8):337-342.
52.
GreffierJPastorMSi-MohamedS, et al. Comparison of two deep-learning image reconstruction algorithms on cardiac CT images: a phantom study. Diagn Interv Imaging. 2024;105(3):110-117.
53.
BeysangAVillaniNBoubakerF, et al. Ultra-high-resolution CT of the temporal bone: comparison between deep learning reconstruction and hybrid and model-based iterative reconstruction. Diagn Interv Imaging. 2024;105(6):233-242.
54.
BoubakerFTeixeiraPAGHossuG, et al. In vivo depiction of cortical bone vascularization with ultra-high resolution-CT and deep learning algorithm reconstruction using osteoid osteoma as a model. Diagn Interv Imaging. 2024;105(1):26-32.
55.
HamardAGreffierJBastideS, et al. Ultra-low-dose CT versus radiographs for minor spine and pelvis trauma: a Bayesian analysis of accuracy. Eur Radiol. 2021;31(4):2621-2633.
56.
GreffierJVillaniNDefezDDabliDSi-MohamedS. Spectral CT imaging: technical principles of dual-energy CT and multi-energy photon-counting CT. Diagn Interv Imaging. 2023;104(4):167-177.
57.
CossetBSigovanMBoccaliniS, et al. Bicolor K-edge spectral photon-counting CT imaging for the diagnosis of thoracic endoleaks: a dynamic phantom study. Diagn Interv Imaging. 2023;104(5):235-242.
58.
Si-MohamedSASigovanMHsuJC, et al. In vivo molecular K-edge imaging of atherosclerotic plaque using photon-counting CT. Radiology. 2021;300:98-107.
59.
CuauLAklPGautheronA, et al. Surface modification effect on contrast agent efficiency for X-ray based spectral photon-counting scanner/luminescence imaging: from fundamental study to in vivo proof of concept. Nanoscale. 2024;16:2931-2944.
60.
FahrniGBoccaliniSMahmoudiA, et al. Quantification of coronary artery stenosis in very-high-risk patients using ultra-high resolution spectral photon-counting CT. Invest Radiol. Published online August 21, 2024; doi.org/10.1097/RLI.0000000000001109.
61.
JacquesTCardotNVentreJDemondionXCottenA. Commercially-available AI algorithm improves radiologists’ sensitivity for wrist and hand fracture detection on X-ray, compared to a CT-based ground truth. Eur Radiol. 2024;34(5):2885-2894.
62.
MichelinBLabaniABilbaultPRoyCOhanaM. Potential added value of an AI software with prediction of malignancy for the management of incidental lung nodules. Res Diagn Interv Imaging. 2023;8:100031.
63.
BennaniSRegnardNEVentreJ, et al. Using AI to improve radiologist performance in detection of abnormalities on chest radiographs. Radiology. 2023;309(3):e230860.
64.
BelkouchiYLederlinMBen AfiaA, et al. Detection and quantification of pulmonary embolism with artificial intelligence: the SFR 2022 artificial intelligence data challenge. Diagn Interv Imaging. 2023;104(10):485-489.
65.
RozwagCValentiniFCottenADemondionXPreuxPJacquesT. Elbow trauma in children: development and evaluation of radiological artificial intelligence models. Res Diagn Interv Imaging. 2023;6:100029.
66.
DupuisMDelbosLRouquetteAAdamsbaumCVeilR. External validation of an artificial intelligence solution for the detection of elbow fractures and joint effusions in children. Diagn Interv Imaging. 2024;105(3):104-109.
67.
Canoni-MeynetLVerdotPDannerACalamePAubryS. Added value of an artificial intelligence solution for fracture detection in the radiologist’s daily trauma emergencies workflow. Diagn Interv Imaging. 2022;103(12):594-600.
68.
FabryVMamaletFLaforetA, et al. A deep learning tool without muscle-by-muscle grading to differentiate myositis from facio-scapulo-humeral dystrophy using MRI. Diagn Interv Imaging. 2022;103(7-8):353-359.
69.
GuenounDZinsMChampsaurPThomassin-NaggaraI; DRIM France AI Study Group. French community grid for the evaluation of radiological artificial intelligence solutions (DRIM France Artificial Intelligence Initiative). Diagn Interv Imaging. 2024;105(2):74-81.
70.
LeclerADuronLSoyerP. Revolutionizing radiology with GPT-based models: current applications, future possibilities and limitations of ChatGPT. Diagn Interv Imaging. 2023;104(6):269-274.
71.
BaratMSoyerPDohanA. Appropriateness of recommendations provided by ChatGPT to interventional radiologists. Can Assoc Radiol J. 2023;74(4):758-763.
72.
Jupin-DelevauxÉDjahnineATalbotF, et al. BERT-based natural language processing analysis of French CT reports: application to the measurement of the positivity rate for pulmonary embolism. Res Diagn Interv Imaging. 2023;6:100027.
73.
KobeATselikasLDeschampsF, et al. Single-session transarterial chemoembolization combined with percutaneous thermal ablation in liver metastases 3 cm or larger. Diagn Interv Imaging. 2022;103(11):516-523.
74.
BonnetBde BaèreTBeunonPFeddalATselikasLDeschampsF. Robotic-assisted CT-guided percutaneous thermal ablation of abdominal tumors: an analysis of 41 patients. Diagn Interv Imaging. 2024;105(6):227-232. doi:10.1016/j.diii.2024.01.005
75.
L’HuillierRDumortierJMastierC, et al. Robotic-assisted percutaneous irreversible electroporation for the treatment of hepatocellular carcinoma. Diagn Interv Imaging. 2023;104(12):615-617.
AujayGEtchegarayCBlancJF, et al. Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma. Diagn Interv Imaging. 2022;103(7-8):360-366.
78.
MeerunMAAllimantCRivièreB, et al. Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery. Hepatobiliary Surg Nutr. 2023;12(3):351-365.
79.
TasuJPVionnetMVelascoSLafitteLPoignardC. Percutaneous irreversible electroporation for the treatment of pancreatic insulinoma. Diagn Interv Imaging. 2023;104(6):307-308.
80.
BaratMDohanAKohiM, et al. Treatment of adenomyosis, abdominal wall endometriosis and uterine leiomyoma with interventional radiology: a review of current evidences. Diagn Interv Imaging. 2024;105(3):87-96.
81.
BachourRSengmanivongNVidalF, et al. Percutaneous cryoablation of abdominal wall endometriosis: an analysis of 38 patients. Diagn Interv Imaging. 2024;105(9):319-325.
82.
BazzocchiAAparisi GómezMPTaninokuchi TomassoniMNapoliAFilippiadisDGuglielmiG. Musculoskeletal oncology and thermal ablation: the current and emerging role of interventional radiology. Skeletal Radiol. 2023;52(3):447-459.
83.
SapovalMQuerubCPereiraH, et al. Genicular artery embolization for knee osteoarthritis: results of the LipioJoint-1 trial. Diagn Interv Imaging. 2024;105(4):144-150.
84.
JungJHMcCutcheonKABorofskyM, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Cochrane Database Syst Rev. 2020;12(12):CD012867.
85.
MarchiAPellerinOQuerubC, et al. Long-term outcomes of prostate artery embolization for acute urinary retention: an analysis of 88 patients. Diagn Interv Imaging. 2023;104(6):292-296.
86.
LoffroyRQuirantesAGuillenK, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients. Diagn Interv Imaging. 2024;105(4):129-136.
